Within the PAD population, as the SPM:prostaglandin ratio increased, there were associated decreases in the monocyte markers CD18, CD36, CD163, CD54, and chemokine receptor 2 (Table 6). The gene discussed is ICAM1; the disease is peripheral arterial disease.